Stay updated with breaking news from Michael Brigham. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Operator: Good morning, and welcome to ImmuCell Corporation Reports First Quarter 2023 Unaudited Financial Results Conference Call. All participants will be in a listen-only mode.
A targeted kinase inhibitor added to a two-drug immunotherapy combination slowed the progression of advanced kidney cancer in previously untreated patients, according to research led by an oncologist from Dana-Farber Cancer Institute.
The Portland-based biotech firm ImmuCell logged $57,000 in net income in the third quarter of the year, up from a loss of $64,000 posted for the same period last year.
Norwich City fans react to the Canaries' 1-1 draw with Reading at Carrow Road.
Operator: Good morning. And welcome to ImmuCell Corporation Reports Third Quarter Fiscal Year 2022 Financial Results Conference Call. All participants will be in a listen-only mode.